This protocol is judged by an institutional overview board, an independent team that critiques any scientific trials involving individuals. If a research consists of a Agenda I drug, as soon as the board approves the protocol as ethical, the scientists have to apply for an investigational new drug (IND) number in the FDA.When beneath the influence